FTC and DOJ Target Healthcare and Life Sciences Industries

FTC and DOJ Target Healthcare and Life Sciences Industries

Client Alert

The healthcare industry remains a focal point of President Biden’s antitrust agenda. The President’s July 2021 Executive Order on Promoting Competition in the American Economy called on federal agencies to focus antitrust enforcement efforts on health care, among other industries, and to coordinate on oversight, investigations, and remedies where agency jurisdiction overlaps. The Federal Trade Commission (FTC), the Department of Justice Antitrust Division (DOJ), and the Department of Health and Human Services (HHS) later announced plans to address antitrust concerns in the healthcare industry. FTC Chair Lina M. Khan highlighted ongoing healthcare-related enforcement initiatives in a February 2024 speech before the American Medical Association. The FTC, DOJ, and HHS launched an interagency inquiry into private equity and corporate ownership in health care shortly thereafter. In this client alert, we summarize the latest federal antitrust activities in the healthcare industry.

Read the full alert.



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.